The symptoms of an incomplete process validation typically manifest as deviations in product quality or inconsistencies in batch records. In this case, the biopharmaceutical facility noticed:Click to read the full…
The scenario commenced when a Quality Control (QC) analyst noted inconsistencies in analytical test results for several batches manufactured under a newly implemented process. Notably, the analyst discovered that specific…
During a routine internal audit, quality assurance (QA) personnel discovered discrepancies in the PPQ summaries compared to the documented acceptance criteria. Initial symptoms included:Click to read the full article.
In this case study, the symptoms of the issue manifested during routine quality checks and production records. The quality control team noted that several batches of the API failed to…
The initial signs of trouble surfaced during a routine internal audit of a sterile manufacturing facility. Team members noted that several manufacturing units had not been requalified within their specified…
During a scheduled FDA inspection, several deviations were noted that raised concerns about process validation compliance. Observations included:Click to read the full article.
In the weeks leading up to a routine FDA inspection, the quality assurance team identified discrepancies in the laboratory while reviewing requalification documentation. Symptoms included:Click to read the full article.
In the presented case, operators in a sterile injectable manufacturing facility reported several anomalies during the batch production of a biopharmaceutical product. Key symptoms included:Click to read the full article.
In a recent incident at a solid dosage form manufacturing facility, several symptoms revealed that a validation protocol deviation had been ignored during the routine requalification of a critical piece…
The first indication of potential issues came during a scheduled internal audit when the QA team identified that the scheduled requalification of a major vessel used in active pharmaceutical ingredient…
During routine quality checks, manufacturing staff observed several discrepancies that led to the discovery of inadequate worst-case justification. Symptoms included:Click to read the full article.